SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026367
Filing Date
2024-08-13
Accepted
2024-08-13 16:00:31
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20240630_10q.htm   iXBRL 10-Q 755459
2 EXHIBIT 31.1 ex_676400.htm EX-31.1 13467
3 EXHIBIT 31.2 ex_676401.htm EX-31.2 13300
4 EXHIBIT 32.1 ex_676402.htm EX-32.1 6741
5 EXHIBIT 32.2 ex_676403.htm EX-32.2 6820
11 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-24-026367.txt   3700953

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240630.xsd EX-101.SCH 39452
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20240630_cal.xml EX-101.CAL 26766
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240630_def.xml EX-101.DEF 220057
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240630_lab.xml EX-101.LAB 211537
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240630_pre.xml EX-101.PRE 244507
57 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240630_10q_htm.xml XML 495921
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 241201187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)